patient_id,note_date,index_date,eligible_label,ineligible_reasons,age,sex,race_ethnicity,height_cm,weight_kg,bmi,smoking_status,alcohol_use,outpatient_visits_last_12m,diagnoses,medications,allergies,pregnancy_status,recent_cardiovascular_event_6m,systemic_steroids_chronic,active_malignancy_systemic_tx_12m,narrative_note
P0006,2025-10-03,2025-10-08,INELIGIBLE,HbA1c below inclusion range (6.4%),58,Male,Black or African American,184,133,39.3,Current,None,2,Type 2 diabetes mellitus; Hypertension; Hyperlipidemia,Metformin ER 1000 mg BID; Atorvastatin 20 mg daily,NKDA,N/A,No,No,No,58-year-old Male with a history of type 2 diabetes diagnosed 10 years ago. Seen for routine outpatient follow-up. Reports no acute complaints. Current therapy: Metformin ER 1000 mg BID; Atorvastatin 20 mg daily. Home glucose readings: fasting 140–190 mg/dL. Comorbidities: hypertension; dyslipidemia. Denies hypoglycemia requiring assistance. Last HbA1c on 2025-10-08 was 6.4%. Plan: optimize regimen and follow-up in 8–12 weeks. Not eligible for cohort due to: HbA1c below inclusion range (6.4%).
